We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+6.16%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$25B
AUM Growth
+$2.37B
Cap. Flow
+$1.17B
Cap. Flow %
4.67%
Top 10 Hldgs %
16.34%
Holding
2,152
New
227
Increased
430
Reduced
632
Closed
714

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$804M
2
ACN icon
Accenture
ACN
+$118M
3
SYY icon
Sysco
SYY
+$76.9M
4
AAPL icon
Apple
AAPL
+$76.7M
5
NTAP icon
NetApp
NTAP
+$69.1M

Sector Composition

Rank Sector Weight
1 Technology 16.58%
2 Healthcare 13.03%
3 Financials 12.46%
4 Consumer Discretionary 10.73%
5 Industrials 9.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MGLN
1676
DELISTED
Magellan Health Services, Inc.
MGLN
-121
Closed -$12K
BMTC
1677
DELISTED
Bryn Mawr Bank Corp
BMTC
-3,630
Closed -$168K
COR
1678
DELISTED
Coresite Realty Corporation
COR
-146
Closed -$16K
HRC
1679
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
-542
Closed -$47K
ECHO
1680
DELISTED
Echo Global Logistics, Inc.
ECHO
-456
Closed -$13K
CSOD
1681
DELISTED
Cornerstone OnDemand, Inc.
CSOD
-852
Closed -$40K
DUKH
1682
DELISTED
Duke Energy Corporation 5.125% Junior Subordinated Debentures due January 15, 2073
DUKH
-600
Closed -$15K
CORE
1683
DELISTED
Core Mark Holding Co., Inc.
CORE
-1,716
Closed -$39K
WRI
1684
DELISTED
Weingarten Realty Investors
WRI
-1,357
Closed -$42K
PRAH
1685
DELISTED
PRA Health Sciences, Inc.
PRAH
-200
Closed -$19K
BPFH
1686
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
-1,550
Closed -$25K
CATM
1687
DELISTED
Cardtronics plc Class A Ordinary Shares (UK)
CATM
-470
Closed -$11K
WFC.PRN
1688
DELISTED
WELLS FARGO & COMPANY Depositary Shares, representing a 1/1,000th interest in a share of Non-Cumulat
WFC.PRN
-1,200
Closed -$30K
WIFI
1689
DELISTED
Boingo Wireless, Inc.
WIFI
-555
Closed -$13K
PRSP
1690
DELISTED
Perspecta Inc. Common Stock
PRSP
-6,141
Closed -$127K
GWPH
1691
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
-315
Closed -$44K
EGOV
1692
DELISTED
NIC Inc
EGOV
-1,930
Closed -$30K
WPX
1693
DELISTED
WPX Energy, Inc.
WPX
-832
Closed -$15K
HDS
1694
DELISTED
HD Supply Holdings, Inc.
HDS
-316
Closed -$14K
GLIBA
1695
DELISTED
GCI Liberty, Inc. Class A Common Stock (DE)
GLIBA
-302
Closed -$14K
MLPI
1696
DELISTED
UBS E-TRACS Alerian MLP Infrastructure ETN
MLPI
-3,867
Closed -$89K
IMMU
1697
DELISTED
Immunomedics Inc
IMMU
-497
Closed -$12K
DTQ
1698
DELISTED
DTE ENERGY COMPANY 2012 Series C 5.25% Junior Subordinated Debentures due 2062
DTQ
-600
Closed -$15K
SOJA
1699
DELISTED
The Southern Company Series 2015A 6.25% Junior Subordinated Notes due October 15, 2075
SOJA
-650
Closed -$17K
AMTD
1700
DELISTED
TD Ameritrade Holding Corp
AMTD
-2,384
Closed -$131K

Similar funds

Glenmede Trust's Q3 2018 Portfolio in Review

As of Q3 2018, Glenmede Trust held 2,152 positions worth $25B, up 11% from $22.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Glenmede Trust deployed $1.17B of net new capital in Q3 2018, opening 227 new positions and adding to 430 existing holdings. Its largest new stake was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $804M trimmed.

  • Glenmede Trust's largest Q3 2018 buy was Vanguard Small-Cap ETF: 518,651 shares worth $84.3M.
  • Glenmede Trust added most to Alphabet (Google) Class A in Q3 2018, an estimated $783M increase.
  • Glenmede Trust's biggest Q3 2018 reduction was Johnson & Johnson, cutting an estimated $804M.
  • Glenmede Trust fully exited BioTelemetry, Inc. in Q3 2018, selling an estimated $43.4M.
  • Glenmede Trust's ten largest holdings make up 16% of its $25B portfolio in Q3 2018.
  • Glenmede Trust opened 227 new positions and closed 714 in Q3 2018.
  • Glenmede Trust's portfolio value rose 11% quarter-over-quarter to $25B.

Based on Glenmede Trust's 13F filing for Q3 2018, filed 15 Nov 2018.